Abstract:Nipah virus (NiV) is an emerging pathogen that causes encephalitis and a high mortality rate in infected subjects. This systematic review aimed to comprehensively analyze the global epidemiology and research advancements of NiV to identify the key knowledge gaps in the literature. Articles searched using literature databases, namely PubMed, Scopus, Web of Science, and Science Direct yielded 5,596 articles. After article screening, 97 articles were included in this systematic review, comprising 41 epidemiological studies and 56 research developments on NiV. The majority of the NiV epidemiological studies were conducted in Bangladesh, reflecting the country's significant burden of NiV outbreaks. The initial NiV outbreak was identified in Malaysia in 1998, with subsequent outbreaks reported in Bangladesh, India, and the Philippines. Transmission routes vary by country, primarily through pigs in Malaysia, consumption of date palm juice in Bangladesh, and human-to-human in India. However, the availability of NiV genome sequences remains limited, particularly from Malaysia and India. Mortality rates also vary according to the country, exceeding 70% in Bangladesh, India, and the Philippines, and less than 40% in Malaysia. Understanding these differences in mortality rate among countries is crucial for informing NiV epidemiology and enhancing outbreak prevention and management strategies. In terms of research developments, the majority of studies focused on vaccine development, followed by phylogenetic analysis and antiviral research. While many vaccines and antivirals have demonstrated complete protection in animal models, only two vaccines have progressed to clinical trials. Phylogenetic analyses have revealed distinct clades between NiV Malaysia, NiV Bangladesh, and NiV India, with proposals to classify NiV India as a separate strain from NiV Bangladesh. Taken together, comprehensive OneHealth approaches integrating disease surveillance and research are imperative for future NiV studies. Expanding the dataset of NiV genome sequences, particularly from Malaysia, Bangladesh, and India will be pivotal. These research efforts are essential for advancing our understanding of NiV pathogenicity and for developing robust diagnostic assays, vaccines and therapeutics necessary for effective preparedness and response to future NiV outbreaks.

Nipah Virus Therapeutics: A Systematic Review to Support Prioritisation for Clinical Trials

Measures to prevent and treat Nipah virus disease: research priorities for 2024-29

Nipah virus disease: what can we do to improve patient care?

A systematic review on Nipah virus: global molecular epidemiology and medical countermeasures development

Bibliometric and Temporal Trend Analysis of Nipah Virus- an Emerging Zoonotic Disease: What Do We Know So Far

Are we ready to fight the Nipah virus pandemic? An overview of drug targets, current medications, and potential leads

A Comprehensive Review on Nipah Virus Infection: Classification, Epidemiology, Treatment and Prevention

Nipah virus: epidemiology, pathogenesis, treatment, and prevention

Nipah Virus: A Multidimensional Update

Advancing the frontiers: Revolutionary control and prevention paradigms against Nipah virus

A systematic review of case reports on mortality, modes of infection, diagnostic tests, and treatments for Nipah virus infection

Recent Advances of Nipah Virus Disease: Pathobiology to Treatment and Vaccine Advancement

Nipah Virus: An Overview of the Current Status of Diagnostics and Their Role in Preparedness in Endemic Countries

Nipah virus and implications for the nursing workforce and public health: A rapid review

Recent Advances in Immunological Landscape and Immunotherapeutic Agent of Nipah Virus Infection

Optimization of Bangladesh and Malaysian genotype recombinant reporter Nipah viruses for in vitro antiviral screening and in vivo disease modeling

Twenty-five years of Nipah outbreaks in Southeast Asia: A persistent threat to global health

Current epidemiology and progress in prevention-treatment of Nipah virus disease

Nipah Virus Outbreaks in Kerala: An Impending Doom?

Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates

Phylogeography, Transmission, and Viral Proteins of Nipah Virus